GlassScriptPhysician profile
John Allan Foster
NPI 1154387751
$4,296.96
in general payments reported to CMS, 2019-2025
23 companies · $647 in 2025
The $647 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $46.52 · 2021: $99.43 · 2022: $2,910 · 2023: $59.10 · 2024: $221 · 2025: $647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $899 · Education: $28.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $898.69 |
| Education | $28.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,867.50 | 2022 | |
| Glaxosmithkline, LLC. | $253.59 | 2024-2025 | Nucala |
| Inspire Medical Systems, INC. | $160.67 | 2024-2025 | Inspire |
| Aerin Medical INC. | $95.88 | 2023-2025 | |
| Acclarent, INC | $92.12 | 2019 | |
| Stryker Corporation | $87.61 | 2019-2025 | Latera |
| Regeneron Healthcare Solutions, INC. | $72.14 | 2023-2025 | Dupixent |
| Smith+Nephew, INC. | $72.07 | 2019-2022 | |
| Optinose US, INC. | $67.31 | 2019-2021 | |
| Lilly USA, LLC | $65.59 | 2024-2025 | Zepbound, Jardiance |
| Alk-Abello, INC | $63.58 | 2019-2021 | |
| Genzyme Corporation | $55.28 | 2019-2024 | |
| Intersect Ent, INC. | $51.56 | 2019 | |
| Phathom Pharmaceuticals, INC. | $51.14 | 2024-2025 | Voquezna |
| Resmed Corp | $43.10 | 2019-2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $37.34 | 2025 | |
| Merck Sharp & Dohme LLC | $34.96 | 2025 | Keytruda |
| Cochlear Americas | $28.11 | 2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Acera Surgical, INC. | $24.82 | 2025 | Restrata Wound Matrix |
| Hikma Pharmaceuticals USA | $22.43 | 2025 | Ryaltris |
| Forte Bio-Pharma LLC | $21.95 | 2021 | |
| Medtronic USA, INC. | $14.62 | 2019 | |
| Laborie Medical Technologies Corp. | $13.59 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.